patents

Shire prevails in Lialda patent case against Allergan
BioPharma Dive
Tue, 03/29/16 - 11:18 am
Shire
Lialda
Allergan
patents
Watson
ulcerative colitis
Amgen Asks the Supreme Court to Reject Challenge to Ruling that Notice of Commercial Marketing is Mandatory, But Asks for Review of Patent Dance Ruling Just in Case
FDA Law Blog
Tue, 03/29/16 - 11:12 am
Amgen
patents
FDA
Zarxio
Neupogen
Patent Payoff? Merck's and Ionis Pharmaceuticals' Take Could Be Tiny
Motley Fool
Sat, 03/26/16 - 01:04 pm
Merck
Gilead Sciences
Ionis Pharmaceuticals
hepatitis C
patents
Harvoni
Sovaldi
Patent troll files swath of suits against ortho companies
Mass Device
Sat, 03/26/16 - 12:47 pm
patents
devices
orthopedic devices
DePuy Synthes Spine
Zimmer Biomet
Strker
ConforMIS
Medacta
Orthopedic Innovations
40% Of Amgen Sales Are Due To Fall Off The Patent Cliff
Seeking Alpha
Fri, 03/25/16 - 09:41 am
Amgen
patents
patent cliff
Patent Troubles Hit Biogen After Gilead, Regeneron; What’s Next?
Bidness, ETC
Fri, 03/25/16 - 09:39 am
Biogen
Gilead
Regeneron
patents
Tecfidera
Harvoni
Sovaldi
Impact Of Merck Litigation On Ionis Pharmaceuticals
Seeking Alpha
Thu, 03/24/16 - 09:47 am
Ionis Pharmaceuticals
Merck
Gilead Sciences
patents
hepatitis C
Gilead's CEO: We are appealing the case
CNBC
Thu, 03/24/16 - 09:29 am
Gilead Sciences
patents
Merck
John Milligan
Harvoni
Sovaldi
hepatitis C
Gilead, Biogen Troubles Remind Investors Why Strong Drug Patents Are Vital
TheStreet.com
Wed, 03/23/16 - 09:24 pm
Gilead Sciences
Biogen
patents
Merck
Kyle Bass
Amgen
Regeneron
Sanofi
Gilead May Have to Pay Rival Merck Billions in Royalties
Fortune
Wed, 03/23/16 - 04:04 pm
Gilead Sciences
Merck
patents
sofosbuvir
Harvoni
Sovaldi
hepatitis C
Merck wins major victory in hep C patent case against Gilead
BioPharma Dive
Wed, 03/23/16 - 09:45 am
Merck
hepatitis C
patents
Gilead Sciences
sofosbuvir
Harvoni
Sovaldi
Amgen's PCSK9 patent win 'reasonably likely' to push Sanofi's Praluent off the market: Analyst
Fierce Pharma
Tue, 03/22/16 - 04:12 pm
Amgen
patents
Sanofi
PCSK9 inhibitors
Regeneron
Repatha
Praluent
How Patent Risk Poses a Big Threat to PDL BioPharma
Motley Fool
Sun, 03/20/16 - 01:28 pm
PDL Biopharma
patents
Gilead And The $3 Billion Merck Issue
Seeking Alpha
Fri, 03/18/16 - 11:10 am
Gilead Sciences
Merck
patents
hepatitis C
Harvoni
Sovaldi
Regeneron, Sanofi Strongly Disagree to Jury’s Verdict in Amgen Patent Trial
Bidness, ETC
Wed, 03/16/16 - 07:22 pm
Sanofi
Regeneron
Amgen
patents
PCSK9
Repatha
Praluent
Biogen’s Best-Selling Drug Loses Patent In EU, Says Cowen
Investors.com
Fri, 03/11/16 - 09:37 am
Biogen
patents
Europe
Tecfidera
MS
multiple sclerosis
Why the Patent Cliff Is a Key Driver of Generic Drug Growth
Yahoo/Market Realist
Thu, 03/3/16 - 02:55 pm
patents
patent cliff
generics
Amgen going after Novartis for Enbrel patent infringement
BioPharma Dive
Thu, 03/3/16 - 10:45 am
Amgen
Novartis
Enbrel
patents
biosimilars
DNA sequencer Illumina sues competitor over nanopore patents
BioPharma Dive
Fri, 02/26/16 - 10:30 pm
DNA sequencing
Illumina
nanopores
patents
Oxford Nanopore
Vivus- Were Qsymia Patents Strong Enough? Actavis Stance Questions That
Seeking Alpha
Fri, 02/26/16 - 10:26 pm
Vivus
Qsymia
patents
Actavis

Pages